What You Should Know
Value-based oncology navigation and management leader Thyme Care announced a Series E financing round exceeding $125M, led by Morgan Health.Strategic and institutional syndication includes major national payers and healthcare venture firms: Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.The company manages more than $7Bin annual oncology spend, with
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
N-Power Medicine Closes $32M to Expand Community Oncology Research
What You Should Know
Oncology drug development platform N-Power Medicine closed a $32M Series B financing round to scale its community oncology clinical research network and expand adoption of its Prospective External Control Arms (ProECA) technology.The financing features Labcorp Venture Fund as a new strategic investor, alongside continued participation from Merck Global Health Innovation Fund (Merck GHI), Innovatus Capital Partners, and a leading U.S.-based biotechnology investor.Solves a
Read More
Craif Secures $33M to Bring AI-Powered Urine Oncology Diagnostics to the U.S.
What You Should Know
Craif Inc., a bio-AI company developing a non-invasive urine analysis platform for early cancer detection, closed an approximately $33M Series D round (¥5.28 billion), bringing its total capital raised to roughly $88M (¥14.2 billion).The financing was co-led by Granite-Integral (a joint venture between Granite Asia and Integral Corporation) and TAUNS Laboratories, Inc. (one of Japan’s largest rapid diagnostic test manufacturers), with participation from U.S.-based
Read More
NYU Langone and Dana-Farber Co-Develop Solavia Decision Suite
What You Should Know
NYU Langone Health and Dana-Farber Cancer Institute have co-developed the Solavia Decision Suite, an oncology decision support platform designed to deliver precise, evidence-based, and standardized care delivery at scale.Solavia launched internally at NYU Langone on June 30, 2026, and is now commercially available to external health systems and oncology centers.Commercialization and external licensing will be managed by NYU Langone’s Technology Opportunities and Ventures,
Read More
Flatiron Health Expands Global Oncology Network via First Partnership in Scotland with NHSGGC
What You Should Know
Flatiron Health UK has partnered with NHS Greater Glasgow and Clyde (NHSGGC), Scotland's largest health board, establishing Flatiron's first research footprint in the Scottish healthcare system.The NHSGGC collaboration contributes to a nearly 70% expansion of Flatiron's international oncology network over the past year, which now spans more than 50 leading sites across the UK, Germany, and Japan.Flatiron's global oncology dataset is constructed from over six million
Read More
Triomics Secures $22M to Automate Oncology AI Chart Abstraction
What You Should Know
Oncology AI innovator Triomics has announced a $22M Series B financing round led by Battery Ventures, pushing its total venture funding past $36 million.The expansion round features strategic backing from Lightspeed, Nexus Venture Partners, Y Combinator, Oncology Ventures, and Precision Health Informatics (a subsidiary of Texas Oncology).Triomics replaces manual medical chart curation by deploying domain-specific AI agents that ingest unstructured longitudinal records,
Read More
The Intelligence Gap: Why Oncologists Are Buried in Data While Patients Wait for Breakthroughs
In 2026, we live in an era of seamless predictive intelligence. For example: My shopping app often anticipates what I’ll need before I’ve even thought about it. My navigation app quietly diverts me away from traffic jams I haven’t encountered yet.
Yet, the moment a patient or clinician steps into the healthcare ecosystem, this "intelligence" seemingly vanishes. For instance, In a typical ten-year cancer survival journey, there are often only 3–4 critical windows where a change in
Read More
Greatly Health Secures $4M to Scale MSK-Validated Integrative Oncology Platform
What You Should Know
Greatly Health raised a $4 million seed round co-led by Pear VC and Commonweal Ventures to bring integrative oncology to a broader patient population.The company's virtual model was originally developed and validated at Memorial Sloan Kettering Cancer Center (MSK).In clinical trials, the program demonstrated a 16% absolute improvement in overall survival at two years and a 69% reduction in hospitalizations.The platform provides live, expert-led group sessions in exercise,
Read More
Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform
What You Should Know:
- VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure's Halo Intelligence™ platform, an AI-powered clinical decision support system that has already increased tumor sequencing rates by 8x for 30,000 patients.
- Through a partnership with Rales' firm New Bearing, VieCure will implement a world-class business system to modernize community oncology clinics, which treat 80% of U.S. cancer
Read More
The Invisible Gap: Why Oncology EHRs Must Measure Emotional Recovery
In oncology care the clinical community has made remarkable progress in extending survival. Yet we face a persistent invisible gap in care: the emotional and cognitive recovery of patients after treatment ends. Emotional distress in cancer survivors such as anxiety, depression, and pain is not only common but also has measurable impacts on utilization, adherence, and quality of life. The next frontier in digital health is to treat this recovery as a data-driven outcome by embedding it into the
Read More
